Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization

by Ming-Yen Hsieh, Zu-Yau Lin, Wan-Long Chuang
Published 2011-08-01

Risk factors for the leakage of chemotherapeutic agents into systemic circulation after transcatheter arterial chemoembolization of hepatocellular carcinoma

by Ming-Yen Hsieh, Zu-Yau Lin, Su-Hwei Chen, Wan-Long Chuang
Published 2011-10-01

Potential risk factors for the reactivation of the replication of hepatitis B and C viruses after transcatheter arterial chemoembolization of hepatocellular carcinoma

by Chia-I. Lin, Zu-Yau Lin, Ming-Yen Hsieh, Chung-Feng Huang, Su-Hwei Chen, Wan-Long Chuang
Published 2011-12-01

Hepatocellular Carcinoma Associated With Liver Abscess

by Ching-I Huang, Liang-Yen Wang, Ming-Lun Yeh, Ming-Yen Hsieh, Jee-Fu Huang, Zu-Yau Lin, Wan-Long Chuang
Published 2009-10-01

Abdominal Splenosis Mimicking Hepatic Tumor: A Case Report

by Ming-Lun Yeh, Liang-Yen Wang, Ching-I Huang, Ming-Yen Hsieh, Zu-Yau Lin, Wan-Long Chuang, Wen-Tsan Chang, Chun-Chieh Wu, Chiao-Yun Chen
Published 2008-11-01

Enhanced enzymatic production of cholesteryl 6ʹ-acylglucoside impairs lysosomal degradation for the intracellular survival of Helicobacter pylori

by Sasikala Muthusamy, Hau-Ming Jan, Ming-Yen Hsieh, Soumik Mondal, Wen-Chun Liu, Yi-An Ko, Wei-Yuan Yang, Kwok-Kong Tony Mong, Guang-Chao Chen, Chun-Hung Lin
Published 2021-10-01

Neoadjuvant transcatheter arterial chemoembolization does not provide survival benefit compared to curative therapy alone in single hepatocellular carcinoma

by Ming-Lun Yeh, Ching-I Huang, Chung-Feng Huang, Ming-Yen Hsieh, Jee-Fu Huang, Chia-Yen Dai, Zu-Yau Lin, Shinn-Cherng Chen, Ming-Lung Yu, Wan-Long Chuang
Published 2015-02-01

Liver function tests may be useful tools for advanced cancer patient care: A preliminary single-center result

by Hui-Ju Tsai, Ming-Yen Hsieh, Yi-Chun Tsai, Zi-Yun Liu, Hui-Ya Hsieh, Chiou-Mei Lee, Ching-Hsin Chien, Yu-Wen Chiu, Hung-Yi Chuang, Chia-Tsuan Huang
Published 2014-03-01

Host and virological characteristics of patients with hepatitis C virus mixed genotype 1 and 2 infection

by Chung-Feng Huang, Ching-I Huang, Ming-Lun Yeh, Jee-Fu Huang, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Ming-Lung Yu, Chia-Yen Dai, Wan-Long Chuang
Published 2015-05-01

Abbott RealTime HBV assay is more sensitive in detection of low viral load and little impacted by drug resistant mutation in chronic hepatitis B patients under nucleot(s)ide analog...

by Ming-Lun Yeh, Chung-Feng Huang, Ching-I Huang, Shu-Fen Liu, Hua-Ling Yang, Ming-Yen Hsieh, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu
Published 2014-01-01

The impact of an additional extra-hepatic primary malignancy on the outcomes of patients with hepatocellular carcinoma.

by Ming-Lun Yeh, Ching-I Huang, Chung-Feng Huang, Ming-Yen Hsieh, Zu-Yau Lin, Jee-Fu Huang, Chia-Yen Dai, Ming-Lung Yu, Shinn-Cherng Chen, Wan-Long Chuang
Published 2017-01-01

Body weight changes in treated hepatitis B patients switching to tenofovir alafenamide☆

by Ming-Lun Yeh, Po-Cheng Liang, Sam Trinh, Ching-I Huang, Chung-Feng Huang, Ming-Yen Hsieh, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Mindie H. Nguyen, Ming-Lung Yu
Published 2022-07-01

Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients.

by Ming-Lun Yeh, Cheng-Yuan Peng, Chia-Yen Dai, Hsueh-Chou Lai, Chung-Feng Huang, Ming-Yen Hsieh, Jee-Fu Huang, Shinn-Cherng Chen, Zu-Yau Lin, Ming-Lung Yu, Wan-Long Chuang
Published 2015-01-01

Lamivudine switch therapy in chronic hepatitis B patients achieving undetectable hepatitis B virus DNA after 3 years of entecavir therapy: A prospective, open-label, multicenter st...

by Ming-Lun Yeh, Ching-I. Huang, Ming-Yen Hsieh, Chung-Feng Huang, Meng-Hsuan Hsieh, Jee-Fu Huang, Chia-Yen Dai, Zu-Yau Lin, Shinn-Chern Chen, Ming-Lung Yu, Wan-Long Chuang
Published 2016-11-01

Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients

by Ming-Yen Hsieh, Chia-Yen Dai, Li-Po Lee, Jee-Fu Huang, Wan-Long Chuang, Nai-Jen Hou, Zu-Yau Lin, Shinn-Cherng Chen, Ming-Yuh Hsieh, Liang-Yen Wang, Wen-Yu Chang, Ming-Lung Yu
Published 2012-02-01

Comparison of Clinical Application of the Abbott HBV PCR Kit and the Versant HBV DNA 3.0 Test to Measure Serum Hepatitis B Virus DNA in Taiwanese Patients

by Jeng-Fu Yang, Ya-Yun Lin, Jee-Fu Huang, Shu-Fen Liu, Pei-Yu Chu, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Liang-Yen Wang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu
Published 2009-08-01

Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein expression predicts disease severity in chronic hepatitis C patients

by Ching-I Huang, Chung-Feng Huang, Ming-Lun Yeh, Yi-Hung Lin, Po-Cheng Liang, Meng-Hsuan Hsieh, Chia-Yen Dai, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Ming-Lung Yu, Wan-Long Chuang
Published 2017-08-01

Qualitative Application of COBAS AMPLICOR HCV Test Version 2.0 Assays in Patients with Chronic Hepatitis C Virus Infection and Comparison of Clinical Performance with Version 1.0

by Ming-Yen Hsieh, Li-Po Lee, Nai-Jen Hou, Jeng-Fu Yang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Zu-Yau Lin, Shinn-Cherng Chen, Ming-Yuh Hsieh, Liang-Yen Wang, Wen-Yu Chang, Ming-Lung Yu
Published 2007-07-01

Hyperuricemia Inversely Correlates with Disease Severity in Taiwanese Nonalcoholic Steatohepatitis Patients.

by Jee-Fu Huang, Ming-Lun Yeh, Ming-Lung Yu, Chung-Feng Huang, Chia-Yen Dai, Ming-Yen Hsieh, Meng-Hsuan Hsieh, Ching-I Huang, Zu-Yau Lin, Shinn-Chern Chen, Pi-Jung Hsiao, Shyi-Jang Shin, Wan-Long Chuang
Published 2015-01-01

Virological predictors of response to retreatment in hepatitis C genotype 2 infected patients.

by Chung-Feng Huang, Chia-Yen Dai, Ming-Lun Yeh, Jee-Fu Huang, Ching-I Huang, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Liang-Yen Wang, Suh-Hang Hank Juo, Wan-Long Chuang, Yi-Ching Lin, Ming-Lung Yu
Published 2013-01-01